Although SMN1 gene deletion represents the primary genetic cause of SMA, the clinical heterogeneity observed among patients with identical genetic backgrounds has highlighted the critical importance of epigenetic regulatory mechanisms in disease manifestation and progression. Here, SMN1 is linked to proximal spinal muscular atrophy.